Differences in miRNA expression in early stage lung adenocarcinomas that did and did not relapse

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Edmonds, Mick D ^a   Eischen, Christine M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LET 7B; MICRORNA; MICRORNA 106B; MICRORNA 151 3P; MICRORNA 187; MICRORNA 205; MICRORNA 215; MICRORNA 449B; MICRORNA 512 3P; MICRORNA 774; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CLINICAL ARTICLE; FEMALE; FROZEN SECTION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC REGULATION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MALE; VERY ELDERLY; ADENOCARCINOMA; COHORT ANALYSIS; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; LUNG; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOGENESIS; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECURRENCE;

EID: 84904298336     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101802     Document Type: Article

References (62)

1. Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Engl J Med 359: 1367-1380.
2. Munker R, Calin GA (2011) MicroRNA profiling in cancer. Clin Sci (Lond) 121: 141-158.
3. Lu Y, Govindan R, Wang L, Liu PY, Goodgame B, et al. (2012) MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer. Carcinogenesis 33: 1046-1054.
4. Tan X, Qin W, Zhang L, Hang J, Li B, et al. (2011) A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Clin Cancer Res 17: 6802-6811.
5. Wang R, Wang ZX, Yang JS, Pan X, De W, et al. (2011) MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 30: 2644-2658.
6. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, et al. (2009) MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 69: 5776-5783.
7. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198. (Pubitemid 43357945)
8. Guan P, Yin Z, Li X, Wu W, Zhou B (2012) Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J Exp Clin Cancer Res 31: 54.
9. Smyth GK (2005) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology 3: 3.
10. Tam S, de Borja R, Tsao MS, McPherson JD (2014) Robust global microRNA expression profiling using next-generation sequencing technologies. Lab Invest 94: 350-358.
11. Perkins JR, Dawes JM, McMahon SB, Bennett DL, Orengo C, et al. (2012) ReadqPCR and NormqPCR: R packages for the reading, quality checking and normalisation of RT-qPCR quantification cycle (Cq) data. BMC Genomics 13: 296.
12. Trujillo RD, Yue SB, Tang Y, O'Gorman WE, Chen CZ (2010) The potential functions of primary microRNAs in target recognition and repression. EMBO J 29: 3272-3285.
13. Hermeking H (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ 17: 193-199.
14. Liu L, Shao X, Gao W, Zhang Z, Liu P, et al. (2012) MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor. FEBS J 279: 3800-3812.
15. Cazzoli R, Buttitta F, Di Nicola M, Malatesta S, Marchetti A, et al. (2013) microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J Thorac Oncol 8: 1156-1162.
16. Kanaan Z, Roberts H, Eichenberger MR, Billeter A, Ocheretner G, et al. (2013) A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Ann Surg 258: 400-408.
17. Jia AY, Castillo-Martin M, Domingo-Domenech J, Bonal DM, Sanchez-Carbayo M, et al. (2013) A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells. Am J Pathol 182: 1171-1179.
18. Zhang QH, Sun HM, Zheng RZ, Li YC, Zhang Q, et al. (2013) Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues. Gene 527: 26-32.
19. Zhu W, Liu X, He J, Chen D, Hunag Y, et al. (2011) Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer 11: 393.
20. Mogilyansky E, Rigoutsos I (2013) The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ 20: 1603-1614.
21. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, et al. (2011) Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer 130: 1378-1386.
22. Georges SA, Biery MC, Kim SY, Schelter JM, Guo J, et al. (2008) Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Cancer Res 68: 10105-10112.
23. Mulrane L, Madden SF, Brennan DJ, Gremel G, McGee SF, et al. (2012) miR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro. Clin Cancer Res 18: 6702-6713.
24. Cai J, Fang L, Huang Y, Li R, Yuan J, et al. (2013) miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in nonsmall cell lung cancer. Cancer Res 73: 5402-5415.
25. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, et al. (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-210. (Pubitemid 351194050)
26. Liang Y (2008) An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer. BMC Med Genomics 1: 61.
27. Xing L, Todd NW, Yu L, Fang H, Jiang F (2010) Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol 23: 1157-1164.
28. Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E (2013) Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Lung Cancer 81: 388-396.
29. Vosa U, Vooder T, Kolde R, Vilo J, Metspalu A, et al. (2013) Meta-analysis of microRNA expression in lung cancer. Int J Cancer 132: 2884-2893.
30. Hu H, Li S, Liu J, Ni B (2012) MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells. Acta Biochim Biophys Sin (Shanghai) 44: 424-430.
31. Xu M, Wang YZ (2013) miR133a suppresses cell proliferation, migration and invasion in human lung cancer by targeting MMP14. Oncol Rep 30: 1398-1404.
32. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256.
33. Mitra R, Edmonds MD, Sun J, Zhao M, Yu H, et al. (2014) Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer. RNA: In press.
34. Jang JS, Jeon HS, Sun Z, Aubry MC, Tang H, et al. (2012) Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin Cancer Res 18: 3658-3667.
35. Rani S, Gately K, Crown J, O'Byrne K, O'Driscoll L (2013) Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma. Cancer Biol Ther 14.
36. Roa WH, Kim JO, Razzak R, Du H, Guo L, et al. (2012) Sputum microRNA profiling: a novel approach for the early detection of non-small cell lung cancer. Clin Invest Med 35: E271.
37. Trevino V, Tadesse MG, Vannucci M, Al-Shahrour F, Antczak P, et al. (2011) Analysis of normal-tumour tissue interaction in tumours: prediction of prostate cancer features from the molecular profile of adjacent normal cells. PLoS One 6: e16492.
38. Schneider S, Park DJ, Yang D, El-Khoueiry A, Sherrod A, et al. (2006) Gene expression in tumor-adjacent normal tissue is associated with recurrence in patients with rectal cancer treated with adjuvant chemoradiation. Pharmacogenet Genomics 16: 555-563. (Pubitemid 44100200)
39. Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, et al. (2013) Acidity generated by the tumor microenvironment drives local invasion. Cancer Res 73: 1524-1535.
40. Qin XQ, Livingston DM, Kaelin WG, Jr., Adams PD (1994) Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci U S A 91: 10918-10922. (Pubitemid 24349596)
41. Gao B, Gao K, Li L, Huang Z, Lin L (2013/11/05) miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC). Biomed Pharmacother.
42. Fassina A, Cappellesso R, Fassan M (2011) Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling. Chest 140: 1305-1311.
43. Wu X, Ajani JA, Gu J, Chang DW, Tan W, et al. (2013) MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer Prev Res (Phila) 6: 196-205.
44. Liu SG, Qin XG, Zhao BS, Qi B, YaoWJ, et al. (2013) Differential expression of miRNAs in esophageal cancer tissue. Oncol Lett 5: 1639-1642.
45. Sugimura K, Miyata H, Tanaka K, Hamano R, Takahashi T, et al. (2012) Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin Cancer Res 18: 5144-5153.
46. Zhao J, Lei T, Xu C, Li H, Ma W, et al. (2013) MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3. Biochem Biophys Res Commun 438: 439-444.
47. Fuse M, Kojima S, Enokida H, Chiyomaru T, Yoshino H, et al. (2012) Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer. J Hum Genet 57: 691-699.
48. Lee K, Kunkeaw N, Jeon SH, Lee I, Johnson BH, et al. (2011) Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. RNA 17: 1076-1089.
49. Jiang L, Chang J, Zhang Q, Sun L, Qiu X (2013) MicroRNA hsa-miR-125a-3p activates p53 and induces apoptosis in lung cancer cells. Cancer Invest 31: 538- 544.
50. Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, et al. (2010) Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer 10: 318.
51. Castilla MA, Moreno-Bueno G, Romero-Perez L, Van De Vijver K, Biscuola M, et al. (2011) Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol 223: 72-80.
52. Chu TH, Yang CC, Liu CJ, Lui MT, Lin SC, et al. (2013) miR-211 promotes the progression of head and neck carcinomas by targeting TGFbetaRII. Cancer Lett 337: 115-124.
53. Cai C, Ashktorab H, Pang X, Zhao Y, Sha W, et al. (2012) MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5. PLoS One 7: e29750.
54. Chang KW, Liu CJ, Chu TH, Cheng HW, Hung PS, et al. (2008) Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma. J Dent Res 87: 1063-1068.
55. Huang JY, Cui SY, Chen YT, Song HZ, Huang GC, et al. (2013) MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression. PLoS One 8: e72615.
56. Edmonds MD, Hurst DR, Welch DR (2009) Linking metastasis suppression with metastamiR regulation. Cell Cycle 8: 2673-2675.
57. Kuner R, Muley T, Meister M, Ruschhaupt M, Buness A, et al. (2009) Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung Cancer 63: 32-38.
58. Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, et al. (2010) Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res 16: 610-619.
59. Nadal E, Chen G, Gallegos M, Lin L, Ferrer-Torres D, et al. (2013) Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma. Clin Cancer Res 19: 6842-6852.
60. Gallardo E, Navarro A, Vinolas N, Marrades RM, Diaz T, et al. (2009) miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis 30: 1903-1909.
61. Graves EE, Maity A, Le QT (2010) The tumor microenvironment in non-small-cell lung cancer. Semin Radiat Oncol 20: 156-163.
62. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, et al. (2005) RAS is regulated by the let-7 microRNA family. Cell 120: 635-647. (Pubitemid 40343076)